CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Amarin Corporation plc - AMRN CFD

    0.7379
    3.62%
    0.0335
    Low: 0.7373
    High: 0.7696
    Market Trading Hours* (UTC) Opens on Monday at 14:30

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0335
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Amarin Corporation PLC ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.7656
    Open* 0.7573
    1-Year Change* -32.57%
    Day's Range* 0.7373 - 0.7696
    52 wk Range 0.65-2.23
    Average Volume (10 days) 1.12M
    Average Volume (3 months) 34.52M
    Market Cap 313.72M
    P/E Ratio -100.00K
    Shares Outstanding 408.29M
    Revenue 322.44M
    EPS -0.13
    Dividend (Yield %) N/A
    Beta 2.11
    Next Earnings Date Feb 14, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 0.7656 0.0310 4.22% 0.7346 0.7773 0.7232
    Nov 29, 2023 0.7378 0.0124 1.71% 0.7254 0.7573 0.7183
    Nov 28, 2023 0.7365 -0.0110 -1.47% 0.7475 0.7577 0.7193
    Nov 27, 2023 0.7658 0.0106 1.40% 0.7552 0.7773 0.7380
    Nov 24, 2023 0.7793 0.0081 1.05% 0.7712 0.7799 0.7565
    Nov 22, 2023 0.7592 0.0038 0.50% 0.7554 0.7743 0.7315
    Nov 21, 2023 0.7524 -0.0218 -2.82% 0.7742 0.7941 0.7512
    Nov 20, 2023 0.7791 -0.0135 -1.70% 0.7926 0.8155 0.7740
    Nov 17, 2023 0.8041 0.0647 8.75% 0.7394 0.8179 0.7263
    Nov 16, 2023 0.7548 0.0102 1.37% 0.7446 0.7644 0.7149
    Nov 15, 2023 0.7473 0.0139 1.90% 0.7334 0.7778 0.7334
    Nov 14, 2023 0.7479 0.0534 7.69% 0.6945 0.7536 0.6880
    Nov 13, 2023 0.6881 -0.0137 -1.95% 0.7018 0.7047 0.6773
    Nov 10, 2023 0.7114 -0.0259 -3.51% 0.7373 0.7473 0.6831
    Nov 9, 2023 0.7273 -0.0191 -2.56% 0.7464 0.7593 0.7152
    Nov 8, 2023 0.7413 -0.0309 -4.00% 0.7722 0.7722 0.7337
    Nov 7, 2023 0.7718 0.0075 0.98% 0.7643 0.7732 0.7412
    Nov 6, 2023 0.7667 0.0553 7.77% 0.7114 0.8003 0.7114
    Nov 3, 2023 0.7189 0.0523 7.85% 0.6666 0.7248 0.6531
    Nov 2, 2023 0.6548 -0.0202 -2.99% 0.6750 0.7068 0.6483

    Amarin Corporation plc Events

    Time (UTC) Country Event
    Wednesday, February 14, 2024

    Time (UTC)

    07:00

    Country

    IE

    Event

    Q4 2023 Amarin Corporation PLC Earnings Release
    Q4 2023 Amarin Corporation PLC Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 369.193 583.187 614.06 429.755 229.214
    Revenue 369.193 583.187 614.06 429.755 229.214
    Cost of Revenue, Total 108.631 121.327 131.444 96.019 54.543
    Gross Profit 260.562 461.86 482.616 333.736 174.671
    Total Operating Expense 475.062 572.685 633.715 454.034 337.439
    Selling/General/Admin. Expenses, Total 304.416 408.334 463.312 323.623 226.996
    Research & Development 30.411 29.307 38.959 34.392 55.2
    Unusual Expense (Income) 31.604 13.717
    Operating Income -105.869 10.502 -19.655 -24.279 -108.225
    Interest Income (Expense), Net Non-Operating 2.804 1.091 2.296 1.873 -7.798
    Other, Net -0.74 -0.302 0.104 -0.075 -0.326
    Net Income Before Taxes -103.805 11.291 -17.255 -22.481 -116.349
    Net Income After Taxes -105.803 7.729 -18 -22.645 -116.445
    Net Income Before Extra. Items -105.803 7.729 -18 -22.645 -116.445
    Net Income -105.803 7.729 -18 -22.645 -116.445
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items -105.803 7.729 -18 -22.645 -116.445
    Income Available to Common Incl. Extra. Items -105.803 7.729 -18 -22.645 -116.445
    Diluted Net Income -105.803 7.729 -18 -22.645 -116.445
    Diluted Weighted Average Shares 401.155 402.48 381.759 342.538 297.237
    Diluted EPS Excluding Extraordinary Items -0.26375 0.0192 -0.04715 -0.06611 -0.39176
    Diluted Normalized EPS -0.21254 0.04253 -0.04715 -0.06611 -0.39176
    Total Extraordinary Items 0 0
    Depreciation / Amortization 0.7
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 80.167 85.975 90.245 89.878 94.44
    Revenue 80.167 85.975 90.245 89.878 94.44
    Cost of Revenue, Total 23.199 25.794 26.641 23.941 35.81
    Gross Profit 56.968 60.181 63.604 65.937 58.63
    Total Operating Expense 104.126 103.316 99.831 95.022 157.272
    Selling/General/Admin. Expenses, Total 50.953 59.587 68.131 58.745 86.893
    Research & Development 5.642 5.681 5.239 5.765 9.356
    Operating Income -23.959 -17.341 -9.586 -5.144 -62.832
    Interest Income (Expense), Net Non-Operating 3.001 2.221 1.563 0.75 0.288
    Other, Net 3.043 0.624 1.25 0.511 -2.255
    Net Income Before Taxes -17.915 -14.496 -6.773 -3.883 -64.799
    Net Income After Taxes -17.56 -16.46 0.856 -5.14 -69.956
    Net Income Before Extra. Items -17.56 -16.46 0.856 -5.14 -69.956
    Net Income -17.56 -16.46 0.856 -5.14 -69.956
    Income Available to Common Excl. Extra. Items -17.56 -16.46 0.856 -5.14 -69.956
    Income Available to Common Incl. Extra. Items -17.56 -16.46 0.856 -5.14 -69.956
    Diluted Net Income -17.56 -16.46 0.856 -5.14 -69.956
    Diluted Weighted Average Shares 407.848 406.177 404.788 404.614 398.187
    Diluted EPS Excluding Extraordinary Items -0.04306 -0.04052 0.00211 -0.0127 -0.17569
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.00428 -0.02091 0.00183 -0.00215 -0.13453
    Unusual Expense (Income) 24.332 12.254 -0.18 6.571 25.213
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 689.098 878.727 879.233 855.005 377.997
    Cash and Short Term Investments 309.361 454.128 500.933 644.588 249.227
    Cash & Equivalents 217.666 219.454 186.964 644.588 249.227
    Total Receivables, Net 130.99 163.653 154.574 116.43 66.523
    Accounts Receivable - Trade, Net 130.99 163.653 154.574 116.43 66.523
    Total Inventory 228.732 234.676 188.864 76.769 57.802
    Prepaid Expenses 19.492 22.352 30.947 13.311 2.945
    Other Current Assets, Total 0.523 3.918 3.915 3.907 1.5
    Total Assets 886.179 1068.06 966.021 882.209 385.714
    Property/Plant/Equipment, Total - Net 9.948 9.085 10.07 10.872 0.063
    Property/Plant/Equipment, Total - Gross 12.42 11.006 11.686 11.891 0.902
    Accumulated Depreciation, Total -2.472 -1.921 -1.616 -1.019 -0.839
    Intangibles, Net 21.78 23.547 13.817 15.258 7.48
    Other Long Term Assets, Total 164.078 121.71 0.432 1.074 0.174
    Total Current Liabilities 259.479 370.682 307.443 242.248 157.263
    Accounts Payable 64.602 114.922 105.876 49.95 37.632
    Accrued Expenses 157.035 207.509 169.855 123.24 76.459
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 50.13 34.24
    Other Current Liabilities, Total 37.842 48.251 31.712 18.928 8.932
    Total Liabilities 290.846 400.966 338.516 273.946 233.384
    Total Long Term Debt 0 0 0 0 46.108
    Long Term Debt 0 46.108
    Other Liabilities, Total 31.367 30.284 31.073 31.698 30.013
    Total Equity 595.333 667.099 627.505 608.263 152.33
    Redeemable Preferred Stock 0 21.85 21.85
    Common Stock 299.002 294.027 290.115 269.173 246.663
    Additional Paid-In Capital 1885.35 1855.25 1817.65 1764.32 1282.76
    Retained Earnings (Accumulated Deficit) -1527.25 -1421.45 -1429.18 -1411.18 -1388.53
    Treasury Stock - Common -61.77 -60.726 -51.082 -35.9 -10.413
    Total Liabilities & Shareholders’ Equity 886.179 1068.06 966.021 882.209 385.714
    Total Common Shares Outstanding 404.346 396.598 392.538 360.104 325.85
    Total Preferred Shares Outstanding 0 289.317 289.317
    Short Term Investments 91.695 234.674 313.969
    Long Term Investments 1.275 34.996 62.469
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 717.511 706.495 683.821 689.098 686.52
    Cash and Short Term Investments 320.662 312.914 304.371 309.361 303.701
    Cash & Equivalents 270.814 232.995 191.412 217.666 240.498
    Short Term Investments 49.848 79.919 112.959 91.695 63.203
    Total Receivables, Net 122.4 122.73 133.236 130.99 123.379
    Accounts Receivable - Trade, Net 122.4 122.73 133.236 130.99 123.379
    Total Inventory 254.461 227.021 225.813 228.732 227.606
    Prepaid Expenses 19.464 43.306 19.878 19.492 27.914
    Other Current Assets, Total 0.524 0.524 0.523 0.523 3.92
    Total Assets 839.031 860.018 860.188 886.179 908.303
    Property/Plant/Equipment, Total - Net 8.657 9.157 9.377 9.948 9.461
    Intangibles, Net 19.676 20.377 21.078 21.78 21.638
    Long Term Investments 0 0.067 0.544 1.275 2.264
    Other Long Term Assets, Total 93.187 123.922 145.368 164.078 188.42
    Total Current Liabilities 266.691 270.932 244.242 259.479 287.356
    Accounts Payable 53.362 54.309 58.779 64.602 93.157
    Accrued Expenses 211.304 214.598 183.264 192.678 192.001
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 2.025 2.025 2.199 2.199 2.198
    Total Liabilities 285.883 290.89 275.395 290.846 320.476
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 19.192 19.958 31.153 31.367 33.12
    Total Equity 553.148 569.128 584.793 595.333 587.827
    Common Stock 302.318 301.906 301.285 299.002 298.596
    Additional Paid-In Capital 1895.16 1891.96 1890.5 1885.35 1878.92
    Retained Earnings (Accumulated Deficit) -1580.58 -1561.27 -1543.71 -1527.25 -1528.11
    Treasury Stock - Common -63.743 -63.464 -63.277 -61.77 -61.585
    Total Liabilities & Shareholders’ Equity 839.031 860.018 860.188 886.179 908.303
    Total Common Shares Outstanding 408.551 408.134 407.266 404.346 403.829
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -105.803 7.729 -18 -22.645 -116.445
    Cash From Operating Activities -180.092 -66.537 -21.746 -9.366 -94.703
    Cash From Operating Activities 0.551 0.587 0.597 0.18 0.023
    Amortization 2.545 2.27 1.441 0.679 0.646
    Deferred Taxes 0
    Non-Cash Items 26.686 38.867 48.05 32.561 20.989
    Cash Taxes Paid -1.782 3.656 0.207 0.067 0.85
    Cash Interest Paid 0 2.043 4.591 21.527
    Changes in Working Capital -104.071 -115.99 -53.834 -20.141 0.084
    Cash From Investing Activities 175.288 104.103 -376.963 -2.478 -0.058
    Capital Expenditures -0.599 -0.252 -2.478 -0.058
    Cash From Financing Activities -0.379 -5.073 -58.907 409.612 271.251
    Financing Cash Flow Items -1.044 -9.644 -15.686 -25.487 -6.344
    Issuance (Retirement) of Stock, Net 0.665 4.571 7.115 466.751 292.285
    Issuance (Retirement) of Debt, Net -50.336 -31.652 -14.69
    Net Change in Cash -5.183 32.493 -457.616 397.768 176.49
    Other Investing Cash Flow Items, Total 175.887 104.103 -376.711
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -16.46 -105.803 -106.659 -101.519 -31.563
    Cash From Operating Activities -7.008 -180.092 -181.644 -163.431 -98.847
    Cash From Operating Activities 0.063 0.551 0.426 0.288 0.144
    Amortization 0.702 2.545 1.909 1.273 0.636
    Non-Cash Items 4.649 26.686 20.358 15.299 6.452
    Cash Taxes Paid 0.038 -1.782 -1.49 -2.112 0.051
    Cash Interest Paid
    Changes in Working Capital 4.038 -104.071 -97.678 -78.772 -74.516
    Cash From Investing Activities -19.61 175.288 203.107 172.239 99.049
    Capital Expenditures -0.599
    Other Investing Cash Flow Items, Total -19.61 175.887 203.107 172.239 99.049
    Cash From Financing Activities 0.364 -0.379 -0.417 -0.261 -0.505
    Financing Cash Flow Items -1.507 -1.044 -0.859 -0.693 -0.535
    Issuance (Retirement) of Stock, Net 1.871 0.665 0.442 0.432 0.03
    Issuance (Retirement) of Debt, Net
    Net Change in Cash -26.254 -5.183 21.046 8.547 -0.303
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Sarissa Capital Management, L.P. Hedge Fund 7.183 29300000 24390000 2023-09-01 LOW
    Kynam Capital Management LP Hedge Fund 2.9418 12000000 0 2023-06-30 MED
    Morgan Stanley & Co. LLC Research Firm 2.669 10887204 -312367 2023-06-30 MED
    Eversept Partners, LP Hedge Fund 2.5746 10502109 -4110648 2023-06-30 HIGH
    Two Sigma Investments, LP Hedge Fund 1.9952 8138690 -364758 2023-06-30 HIGH
    Tang Capital Management, LLC Hedge Fund 1.7406 7100000 1700000 2023-06-30 MED
    SCP Investment, LP Hedge Fund 1.5935 6500000 0 2023-06-30 MED
    DG Capital Management, LLC Investment Advisor/Hedge Fund 1.3421 5474753 0 2023-06-30 HIGH
    13D Management LLC Investment Advisor 1.0006 4081400 -85500 2023-06-30 MED
    ExodusPoint Capital Management, LP Hedge Fund 0.9545 3893310 3893310 2023-06-30 HIGH
    Millennium Management LLC Hedge Fund 0.6035 2461684 -3362066 2023-06-30 HIGH
    Woodline Partners LP Hedge Fund 0.5516 2250000 250000 2023-06-30 HIGH
    MFP Investors, LLC Investment Advisor 0.5442 2220000 106170 2023-06-30 MED
    Longitude (Cayman) Ltd Investment Advisor 0.3395 1385000 135000 2023-06-30 MED
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.325 1325894 18162 2023-06-30 LOW
    Axxcess Wealth Management, LLC Investment Advisor 0.2989 1219328 500796 2023-06-30 MED
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.2898 1182090 -2125468 2023-06-30 MED
    PSM Vermögensverwaltung GmbH Investment Advisor 0.2721 1110100 160000 2023-09-30 HIGH
    Citadel Advisors LLC Hedge Fund 0.1891 771268 -4349377 2023-06-30 LOW
    OneDigital Investment Advisors LLC Investment Advisor 0.1856 757280 -11500 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Amarin Corporation plc Company profile

    Amarin Corporation (AMRN) is a clinical-stage biopharmaceutical company focused on the commercialisation and improvement of therapeutics to cure and deal with cardiovascular diseases. 

    Established in 1989, Amarin is headquartered in Dublin, Ireland, and operates in several European countries, the United States, Canada, Lebanon and the United Arab Emirates. 

    The company’s lead commercial product VASCEPA (icosapent ethyl) is a prescription-only omega-3 fatty acid product. Taken as an adjunct to diet, it reduces triglyceride levels in adult patients suffering from severe hypertriglyceridemia. The drug helps to address cardiovascular risk for millions of patients.

    VASCEPA was launched in the United States in 2013, but gained wider recognition in 2019  as the US Food and Drug Administration (FDA) approved Amarin for a broader indication for cardiovascular risk reduction in studied high-risk patients. It has also got approval from the European Commission to reduce the risks for cardiac patients.

    Amarin still prices VASCEPA at a considerably lower level than other new drugs of its category. 

    Formerly known as Ethical Holdings, the company changed its name to Amarin Corporation in 1999. The company went public in July 2019. It trades on the Nasdaq under the ticker ‘AMRN’.

    Industry: Bio Therapeutic Drugs

    First Floor, Block 3, The Oval,
    Shelbourne Road, Ballsbridge
    DUBLIN
    IE

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    BTC/USD

    38,761.00 Price
    +2.540% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.62 Price
    +0.910% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Gold

    2,072.25 Price
    +1.760% 1D Chg, %
    Long position overnight fee -0.0193%
    Short position overnight fee 0.0111%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading